1. Report Brief. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Institute of Medicine of the National Academies. 2011. http://iom.nationalacademies.org/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research/Report-Brief.aspx
. Accessed 19 Aug 2015.
2. Schaefer C, Sadosky A, Mann R, Daniel S, Parsons B, Tuchman M, et al. Pain severity and the economic burden of neuropathic pain in the United States: BEAT neuropathic pain observational study. Clinicoecon Outcomes Res. 2014;6:483–96.
3. Epilepsy Fast Facts. Atlanta, GA: Centers for Disease Control and Prevention; 2015.
http://www.cdc.gov/epilepsy/basics/fast-facts.htm
. Accessed 15 Dec 2015.
4. Lyrica (pregabalin) [US prescribing information]. New York, NY: Pfizer; 2013.
http://labeling.pfizer.com/ShowLabeling.aspx?id=561
. Accessed 26 Aug 2015.
5. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice ASC, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology 2015;14(2):162–173.